人iPSC模型内源性表达4R tau自发形成晚期tau蛋白病理性
研究构建了经工程化改造、内源性表达成人脑样4R tau异构体的人诱导多能干细胞衍生神经元模型,无需外源tau病理种子即可自发形成晚期tau蛋白病标志。模型神经元内积累具有播种活性的过度磷酸化tau缠结样结构;仅表达突变4R而无3R时病理显著加重。该模型可用于测试化学疾病调节剂和评估人tau PET示踪剂,支持tau蛋白病机制研究与药物开发。
要点
- 内源性4R tau表达足以在工程化人iPSC神经元中自发形成晚期tau病理。
- 突变4R单独表达、缺乏3R时tau错误折叠与聚集显著加重。
- 该模型可用于化学调节剂筛选与人tau PET示踪剂评估。
核心结论
- 4R tau异构体表达对人神经元tau蛋白病发病机制具有核心作用,该模型可支持tau蛋白病机制研究与疾病修饰药物开发。
研究设计与样本
- 研究采用工程化改造、含协同tau突变的人诱导多能干细胞衍生神经元,诱导成人脑样4R tau异构体内源性表达,不添加外源tau病理来源。
主要发现
- 诱导4R tau表达后,神经元内积累具有播种活性的过度磷酸化tau,形成缠结样结构。
- 仅表达突变4R而缺乏3R tau异构体时,tau错误折叠与聚集不成比例地加重。
- 模型可翻译应用于测试化学疾病调节剂和评估人tau PET示踪剂。
临床怎么用
- 该人iPSC模型可作为平台用于tau蛋白病机制解析、化学疾病调节剂筛选及人tau PET示踪剂评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tauopathies, such as Alzheimer's disease and frontotemporal dementia, are common neurodegenerative diseases characterized by misfolding, hyperphosphorylation, and aggregation of tau. Molecular mechanisms underlying tauopathies are still poorly understood, which is in part due to a lack of human models autonomously developing major disease hallmarks. The formation of late-stage disease phenotypes may require adult tau isoform expression, which contributes to tau pathogenesis but is challenging to replicate in human stem cell-derived systems, thus impeding research on underlying mechanisms and drug development. Here, we show that induction of adult human brain-like 4R tau isoform expression enables cell-intrinsic formation of late-stage tauopathy hallmarks in induced pluripotent stem cell-derived neurons engineered to contain synergistic tau mutations without exogenous sources of tau pathology. Neurons accumulated seeding-competent and hyperphosphorylated tau in tangle-like structures. Furthermore, exclusive expression of mutant 4R in the absence of the 3R tau isoform disproportionately intensified pathology, resulting in abundant tau misfolding and aggregation. Last, we provide proof of principle that our model can be translationally applied both to test chemical disease modulators and evaluate human tau PET tracers. Collectively, our model corroborates the central role of 4R tau isoform expression for pathogenesis in human neurons and enables investigations to elucidate mechanisms underlying human tauopathy formation. Moreover, it may serve as a platform supporting urgently needed development of disease-modifying drugs.
引用
- Dannert A, Schulz N, Klimmt J, et al. A human iPSC model of tauopathies engineered for 4R tau isoform expression endogenously develops late-stage neuronal tau pathology. Sci Transl Med. 2026. PMID: 41950304. doi:10.1126/scitranslmed.adu9845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。